Literature DB >> 25156735

Localization of Burkholderia cepacia complex bacteria in cystic fibrosis lungs and interactions with Pseudomonas aeruginosa in hypoxic mucus.

Ute Schwab1, Lubna H Abdullah2, Olivia S Perlmutt2, Daniel Albert3, C William Davis2, Roland R Arnold4, James R Yankaskas2, Peter Gilligan5, Heiner Neubauer6, Scott H Randell2, Richard C Boucher2.   

Abstract

The localization of Burkholderia cepacia complex (Bcc) bacteria in cystic fibrosis (CF) lungs, alone or during coinfection with Pseudomonas aeruginosa, is poorly understood. We performed immunohistochemistry for Bcc and P. aeruginosa bacteria on 21 coinfected or singly infected CF lungs obtained at transplantation or autopsy. Parallel in vitro experiments examined the growth of two Bcc species, Burkholderia cenocepacia and Burkholderia multivorans, in environments similar to those occupied by P. aeruginosa in the CF lung. Bcc bacteria were predominantly identified in the CF lung as single cells or small clusters within phagocytes and mucus but not as "biofilm-like structures." In contrast, P. aeruginosa was identified in biofilm-like masses, but densities appeared to be reduced during coinfection with Bcc bacteria. Based on chemical analyses of CF and non-CF respiratory secretions, a test medium was defined to study Bcc growth and interactions with P. aeruginosa in an environment mimicking the CF lung. When test medium was supplemented with alternative electron acceptors under anaerobic conditions, B. cenocepacia and B. multivorans used fermentation rather than anaerobic respiration to gain energy, consistent with the identification of fermentation products by high-performance liquid chromatography (HPLC). Both Bcc species also expressed mucinases that produced carbon sources from mucins for growth. In the presence of P. aeruginosa in vitro, both Bcc species grew anaerobically but not aerobically. We propose that Bcc bacteria (i) invade a P. aeruginosa-infected CF lung when the airway lumen is anaerobic, (ii) inhibit P. aeruginosa biofilm-like growth, and (iii) expand the host bacterial niche from mucus to also include macrophages.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25156735      PMCID: PMC4249344          DOI: 10.1128/IAI.01876-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  77 in total

Review 1.  Respiratory tract mucin genes and mucin glycoproteins in health and disease.

Authors:  Mary Callaghan Rose; Judith A Voynow
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

2.  Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients.

Authors:  Umadevi Sajjan; Mary Corey; Atul Humar; Elizabeth Tullis; Ernest Cutz; Cameron Ackerley; Janet Forstner
Journal:  J Med Microbiol       Date:  2001-06       Impact factor: 2.472

3.  P2u purinoceptor regulation of mucin secretion in SPOC1 cells, a goblet cell line from the airways.

Authors:  L H Abdullah; S W Davis; L Burch; M Yamauchi; S H Randell; P Nettesheim; C W Davis
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

4.  The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility.

Authors:  Birgit Huber; Kathrin Riedel; Morten Hentzer; Arne Heydorn; Astrid Gotschlich; Michael Givskov; Søren Molin; Leo Eberl
Journal:  Microbiology (Reading)       Date:  2001-09       Impact factor: 2.777

5.  Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles.

Authors:  Julie Lamothe; Kassidy K Huynh; Sergio Grinstein; Miguel A Valvano
Journal:  Cell Microbiol       Date:  2006-07-26       Impact factor: 3.715

6.  Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology.

Authors:  Kelli L Palmer; Lauren M Mashburn; Pradeep K Singh; Marvin Whiteley
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

7.  L-arginine utilization by Pseudomonas species.

Authors:  V Stalon; A Mercenier
Journal:  J Gen Microbiol       Date:  1984-01

8.  Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration.

Authors:  R S Baltimore; C D Christie; G J Smith
Journal:  Am Rev Respir Dis       Date:  1989-12

9.  Immigration and emigration of Burkholderia cepacia and Pseudomonas aeruginosa between and within mixed biofilm communities.

Authors:  A G Al-Bakri; P Gilbert; D G Allison
Journal:  J Appl Microbiol       Date:  2004       Impact factor: 3.772

10.  Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patients.

Authors:  Suphan Bakkal; Sandra M Robinson; Claudia L Ordonez; David A Waltz; Margaret A Riley
Journal:  Microbiology (Reading)       Date:  2010-04-08       Impact factor: 2.777

View more
  49 in total

1.  Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the antimicrobial activities of neutrophil-like dHL60 cells.

Authors:  Mark P Murphy; Emma Caraher
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

2.  Regulator LdhR and d-Lactate Dehydrogenase LdhA of Burkholderia multivorans Play Roles in Carbon Overflow and in Planktonic Cellular Aggregate Formation.

Authors:  Inês N Silva; Marcelo J Ramires; Lisa A Azevedo; Ana R Guerreiro; Andreia C Tavares; Jörg D Becker; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

3.  σ54-Dependent Response to Nitrogen Limitation and Virulence in Burkholderia cenocepacia Strain H111.

Authors:  Martina Lardi; Claudio Aguilar; Alessandro Pedrioli; Ulrich Omasits; Angela Suppiger; Gerardo Cárcamo-Oyarce; Nadine Schmid; Christian H Ahrens; Leo Eberl; Gabriella Pessi
Journal:  Appl Environ Microbiol       Date:  2015-04-03       Impact factor: 4.792

4.  Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin.

Authors:  Jeffrey M Flynn; Chi Phan; Ryan C Hunter
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

5.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

6.  Use of Synthetic Hybrid Strains To Determine the Role of Replicon 3 in Virulence of the Burkholderia cepacia Complex.

Authors:  Kirsty Agnoli; Roman Freitag; Margarida C Gomes; Christian Jenul; Angela Suppiger; Olga Mannweiler; Carmen Frauenknecht; Daniel Janser; Annette C Vergunst; Leo Eberl
Journal:  Appl Environ Microbiol       Date:  2017-06-16       Impact factor: 4.792

7.  Pseudomonas aeruginosa-Derived Rhamnolipids and Other Detergents Modulate Colony Morphotype and Motility in the Burkholderia cepacia Complex.

Authors:  Steve P Bernier; Courtney Hum; Xiang Li; George A O'Toole; Nathan A Magarvey; Michael G Surette
Journal:  J Bacteriol       Date:  2017-06-13       Impact factor: 3.490

Review 8.  Cystic Fibrosis: Microbiology and Host Response.

Authors:  Edith T Zemanick; Lucas R Hoffman
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

9.  Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.

Authors:  Saira Ahmad; Jean Tyrrell; William G Walton; Ashutosh Tripathy; Matthew R Redinbo; Robert Tarran
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

10.  Host Adaptation Predisposes Pseudomonas aeruginosa to Type VI Secretion System-Mediated Predation by the Burkholderia cepacia Complex.

Authors:  Andrew I Perault; Courtney E Chandler; David A Rasko; Robert K Ernst; Matthew C Wolfgang; Peggy A Cotter
Journal:  Cell Host Microbe       Date:  2020-08-04       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.